Sunday, July 23, 2006

GSK's "switch pitch" to Pfizer's OTC people

In the wake of Pfizer's decision last month to sell its Morris Plains-based consumer products division to Johnson & Johnson for $16.6 billion, nearby rival GlaxoSmithKline has decided to place some in-your face advertising to encourage worried scientists and execs to switch allegiances.

"Integration of businesses can take a long time, create uncertainty and often have casualties based on redundancy of talent," Glaxo said in full-page ads that ran in several local newspapers last week aimed particularly at marketers and scientists.

"But this much is certain -- you have choices. "

You certainly do.

No comments: